Analysis of the effects of indomethacin on SARS-CoV-2 infection and the inflammatory response associated with the purinergic system

Souza et al., Master's Dissertation, Mar 2023
Vero E6 and Calu-3 in vitro study showing that indomethacin protects against SARS-CoV-2-induced cytopathic effects and suppresses ATP-associated inflammatory responses.
7 preclinical studies support the efficacy of indomethacin for COVID-19:
Souza et al., 31 Mar 2023, peer-reviewed, 1 author.
In vitro studies are an important part of preclinical research, however results may be very different in vivo.